논문 11 페이지 | PnH

최근소식

회사소개 사업소개 치료기술 암종별치료 최근소식 고객센터

논문 치료사례 동영상게시판 사진게시판

논문

번호 제목 날짜

285

2024년 Nature Biotechnology:A CAR enhancer increases the activity and persistence of CAR T cells

2024년 Nature Biotechnology:A CAR enhancer increases the activity and persistence of CAR T cells
2024-08-29
284

2024년 Science ImmunologyCD5 deletion enhances the antitumor activity of adoptive T cell therapies

2024년 Science ImmunologyCD5 deletion enhances the antitumor activity of adoptive T cell therapies
2024-08-28
283

2024년 Molecular Therapy—Methods & Clinical DevelopmentMetabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence

2024년 Molecular Therapy—Methods & Clinical DevelopmentMetabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
2024-08-28
282

2024년 Science Translational MedicineLisocabtagene maraleucel in follicular lymphoma the phase 2 TRANSCEND FL study

2024년 Science Translational MedicineLisocabtagene maraleucel in follicular lymphoma the phase 2 TRANSCEND FL study
2024-08-28
281

2024년 7월 CAR-T 연구 발표 및 루프스 치료 결과

2024년 7월 CAR-T 연구 발표 및 루프스 치료 결과
2024-08-22
280

2024년 7월 면역세포치료 논문발표

2024년 7월 면역세포치료 논문발표
2024-08-22
279

2024년 LancetCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy a dose-finding phase 1 study

2024년 LancetCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy a dose-finding phase 1 study
2024-08-13
278

2024년 Science Translational Medicine: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

2024년 Science Translational Medicine: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study
2024-08-13
277

2024년 Science Immunology :CD5 deletion enhances the antitumor activity of adoptive T cell therapies

2024년 Science Immunology :CD5 deletion enhances the antitumor activity of adoptive T cell therapies
2024-08-11
276

2024년 Nature Medicine: Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results

2024년 Nature Medicine: Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
2024-07-30